Management of Patients with Acute Coronary Syndromes: What is the Clinical Role of Direct Thrombin Inhibitors?

ISSN： 0012-6667

Source： Drugs, Vol.62, Iss.13, 2002-01, pp. : 1839-1852

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Direct Thrombin Inhibitors for the Treatment of Acute Coronary Syndromes and During Percutaneous Coronary Interventions

Current Pharmaceutical Design, Vol. 11, Iss. 30, 2005-11 ,pp. : 3919-3929

Bentham Science Publishers

Access to resources Recommend Favorite

Antibiotics for Myocardial Infarction?: A Possible Role of Infection in Atherogenesis and Acute Coronary Syndromes

By Schussheim A.E. Fuster V.

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 283-291

Adis International

Access to resources Recommend Favorite

The Extended Role of the Clinical Pharmacist in the Management of Heart Failure and Acute Coronary Syndromes

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 32, Iss. 1, 2002-03 ,pp. : 17-23

John Wiley & Sons Inc

Access to resources Recommend Favorite

Who Should Receive HMG CoA Reductase Inhibitors?

By Teo K.K.

Drugs, Vol. 62, Iss. 12, 2002-01 ,pp. : 1707-1715

Adis International

Access to resources Recommend Favorite

The role of antiplatelet therapy in the management of acute coronary syndromes

By Volturo Gregory A Mazzola Jennifer L Przylenk Karin

Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. : 541-556

Informa Healthcare

Access to resources Recommend Favorite